Mirae Asset Global Investments Co., Ltd. Rocket Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,292 shares of RCKT stock, worth $57,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,292
Previous 2,710
21.48%
Holding current value
$57,445
Previous $58,000
3.45%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RCKT
# of Institutions
195Shares Held
92.4MCall Options Held
222KPut Options Held
111K-
Rtw Investments, LP New York, NY17.7MShares$309 Million6.36% of portfolio
-
Wellington Management Group LLP Boston, MA9.16MShares$160 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$108 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.81MShares$101 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.33MShares$75.5 Million0.47% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.32B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...